IBioIC is hosting an Investor event to give companies the opportunity to meet with a range of local and international Investors.
Investing in Biotech is part of a series of events running alongside the IBioIC 2019 Annual Conference.
The Investor event will offer companies attending the conference the opportunity to book meetings with a range of local and international investors in the Bioeconomy over both days of the conference.
The event will take place in one of the meeting rooms adjacent to the main conference exhibition area and delegates will be able to arrange meetings via the conference partnering system.
To book a meeting with an investor, delegates need to be registered to attend IBioIC19. Conference delegates will be advised when the partnering system is launched in mid-January and will be able to arrange meetings on a first-come, first-served basis.
The Investors
Thomas Grotkjaer, Novo Holdings
Novo Holdings (NH) is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation. NH is the holding company of the Novo Group and manages the Foundation’s investment assets. In addition to being the major shareholder in the Novo Group companies (Novo Nordisk, Novozymes, NN IT), NH invests the wealth of the Foundation in two key categories: 1. Life Science Investments, including industrial biotechnology (all stages of development); and 2. Financial Investments.
Sarah Hardy, Archangels
Archangels is a prominent business angel syndicate which has been at the forefront of early stage investing in Scotland for more than a quarter of a century. It looks to invest in companies with high growth potential in the technology and life science sectors.
Our investee companies:
Must have high growth and international sales potential;
Should have defensible technology, with clear intellectual property
Must be based in Scotland; and
Should be in a sector that qualifies under the Enterprise Investment Scheme.
Poonam Malik, Investing Women
Investing Women Angels are Scotland’s only female angel investment group. The majority of our investments have been in BioTech and tech based companies but we are always willing to look wider for opportunities. We tend to invest seed capital in early stage ventures. We don’t exclusively invest in female led businesses but if you have at least one female founder in a senior decision making role, that will make an investment more appealing to us.
